Georg
Geisberger
a,
Emina Besic
Gyenge
b,
Doris
Hinger
b,
Peter
Bösiger
a,
Caroline
Maake
b and
Greta R.
Patzke
*a
aInstitute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. E-mail: greta.patzke@aci.uzh.ch; Fax: (+) 41 44 635 6802
bInstitute of Anatomy, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
First published on 9th May 2013
A fluorescent labeled Wells–Dawson type POM ({P2W17O61Fluo}) was newly synthesized and characterized by a wide range of analytical methods. {P2W17O61Fluo} was functionalized with fluorescein amine through a stable amide bond, and its long time stability was verified by UV/vis spectroscopic techniques at physiologically relevant pH values. No significant impact on the cell viability or morphology of HeLa cells was observed for POM concentrations up to 100 μg mL−1. Cellular uptake of fluorescent {P2W17O61Fluo} was monitored by confocal laser scanning microscopy. POM uptake occurs mainly after prolonged incubation times of 24 h resulting in different intracellular patterns, i.e. randomly distributed over the entire cytoplasm, or aggregated in larger clusters. This direct monitoring strategy for the interaction of POMs with cells opens up new pathways for elucidating their unknown mode of action on the way to POM-based drug development.
However, the multitude of empirical bioactivity data derived from POM-based in vitro and in vivo studies12 did not afford a proportional degree of insight into their biochemical pathways. Localization of POMs in cells and clarification of their metabolization after endocytosis would provide essential information for understanding their modes of action. Tracking of POMs in cellular environments is furthermore indispensable to control their adverse effects, such as cytotoxicity, and to circumvent instability under physiological conditions. Over the past few years, an increasing number of drug delivery approaches for POM encapsulation has been developed, such as efficient anticancer POM–liposome composites.13–16 Nevertheless, informed development of POM-based drug prototypes is delayed by a lack of direct visualization techniques.
Our recent studies were thus focused on nanocapsules based on bioactive POMs and various chitosan derivatives, preferably carboxymethyl chitosan (CMC) and trimethyl chitosan (TMC). These nanocomposites combine stability under ambient conditions with significantly lowered POM cytotoxicity.17,18 Next, we demonstrated that POM–CMC composites can be safely shuttled into cancer cells. For the first time, we directly observed cellular uptake of bioactive POM composites: complementary CLSM (confocal laser scanning microscopy) and TEM (transmission electron microscopy) techniques on labeled and unlabeled nanocomposites, respectively, revealed that they are taken up within less than 1 h with a strong preference for the perinuclear region of HeLa cells.19 As the next step towards elucidation of biochemical POM routes, we here present new evidence for cellular uptake of pristine POMs.
Microscopic tracking of fluorescent POMs containing lanthanoid heteroatoms, such as europium or gadolinium, appears to be the most straightforward approach at first glance. Unfortunately, it cannot be directly applied in biological media, because the luminescence of Ln-containing POMs can only be monitored in the solid state, whereas it is quenched in aqueous solutions by hydrate layers.20,21 This renders attachment of a fluorescent dye to bioactive POMs a very promising strategy. However, derivatization of POMs with organic residues remains a challenge, and only a few approaches hitherto have been established to connect POM moieties with fluorescent dyes.22–24 Moreover, the instability of many POMs at physiological pH severely limits the number of suitable candidates for such labeling reactions.
Viable routes towards stable organic functionalization of POMs have been published by Bareyt et al. and Carraro et al.25,26 The first approach introduces POMs equipped with Sn-organyl derivatives carrying a carboxyl group, and the latter study modifies POMs with Si-organyls containing amino groups. Tin-functionalized POMs have furthermore been evaluated for their inhibitory potential against protein kinase CK2.27 Here, we employ the Sn-organyl route via carboxyl-functionalized POMs for coupling reactions with fluorescein through amide bond formation.28,29 The target POM TBA6K[α2-P2W17O61{Sn(CH2)2CONHC20H11O5}] contains the lacunary [α2-P2W17O61]10− derivative of the Wells–Dawson polyanion [P2W18O62]6−, which is a prototype bioactive POM. It excels through antibacterial activity against resistant strains and has been widely investigated and derivatized as an anti-HIV agent.30–32 Insulin mimetic33 and neurite outgrowth effects34 furthermore amplify the bio-medical spectrum of Wells–Dawson-type POMs. Concerning their lacunary derivatives, interaction of [P2W17O61]10− with human serum albumin (HSA) has been studied.35 Zr-substituted derivatives have recently been identified as selective catalysts for peptide bond hydrolysis,36 while gadolinium introduction opens up new possibilities for MRI contrast agents.37,38
In the following, we present the synthesis and characterization of fluorescent labeled Wells–Dawson POMs, followed by direct monitoring of their interaction with cancer cells.
![]() | ||
Fig. 1 Synthesis of TBA6K[α2-P2W17O61{Sn(CH2)2CONHC20H11O5}] labeled with fluorescein amine. |
Stability of {P2W17O61Fluo} was investigated under conditions as close as possible to cell culture media (PBS, pH 7.2). Analogous to cellular uptake experiments, the labeled POM was first dissolved in DMSO to yield a 0.3% (v/v) DMSO in PBS solution after combination of both media. Interestingly, {P2W17O61Fluo} did not precipitate upon PBS addition, thus eliminating the need for subsequent ion exchange reactions prior to cellular uptake tests.
The solubility of TBA-{P2W17O61Fluo} in aqueous media strongly depends on their components in combination with the pH value: dissolution was observed in PBS or cell culture medium (DMEM) at pH values above 7, whereas precipitation sets in at lower pH values or in water.
The UV/vis spectrum of {P2W17O61Fluo} in PBS (Fig. 2) clearly indicates its stability around neutral pH conditions through monitoring of the characteristic POM absorption bands, i.e. two charge-transfer shoulders (O → W) at 257 and 289 nm and a fluorescein-based absorption with a maximum at 458 nm (Fig. 2b) which overlaps with POM bands in the UV region. These characteristic POM absorption bands did not undergo significant changes at any wavelength over a period of 5 days (Fig. S4†). These results agree well with the previously observed stability of a representative Sn-substituted Wells–Dawson type POM in physiological media.25
![]() | ||
Fig. 3 FT-IR spectra of (a) fluorescein amine, (b) {P2W17O61}, (c) {P2W17O61Sn} and (d) {P2W17O61Fluo}. |
![]() | ||
Fig. 4 MTT assays of TBA- and Na-{P2W17O61Fluo}. |
![]() | ||
Fig. 5 (a) Confocal picture of HeLa cells with stained nucleus (blue) incubated with 50 μg mL−1 TBA-{P2W17O61Fluo} (green) for 24 h; (b) confocal picture merged with the DIC image showing the intact cell morphology. |
POM uptake was monitored by CLSM on HeLa cells, and Fig. 5 shows the cells after 24 h of incubation with fluorescent {P2W17O61Fluo}.
POM localization exhibits two different patterns, namely random distribution or formation of large clusters in the cell cytoplasm. It is currently not clear whether this is the result of e.g. alternative internalization modes or intracellular processing pathways. Colocalization with mitochondria was not observed, but cluster accumulation might occur in trafficking or recycling vesicles. However, distributions of {P2W17O61Fluo} signals were notably different from those found in our previous study with fluorescent labeled POM nanocomposites that featured mainly perinuclear localization.19 Given that TBA- and Na-salts of {P2W17O61Fluo} did not differ significantly with respect to cellular uptake, the countercation does not appear to play a crucial role in the process.
Location of {P2W17O61Fluo} within HeLa cells after 24 h of incubation was furthermore verified by z-stack recordings. Section views focusing on a selected POM cluster located in all planes are shown in Fig. S6a, and Fig. S6b† provides a 3D maximum projection visualizing the amounts and cluster shapes of POMs within cells. Note that strong and homogeneous POM uptake is not equally displayed by all cells. This may be due to active POM uptake and might thus reflect inhomogeneous activity of the cell population, but further investigations using immunocytochemistry methods are required to track endocytotic pathways.
Fluorescent labeled POMs were never found to enter the nucleus, regardless of concentration or incubation time. This key observation does not support any active interaction of POMs with nuclear DNA and their role as possible mutagens under the given conditions. This also sheds new light on the antiviral properties and additional bio-medical effects of Dawson-type POMs which are probably proceeding without direct POM–DNA interactions.31
Earlier, Cibert and Jasmin employed different spectroscopic methods to demonstrate that ammonium-21-tungsto-9-antimonate (HPA-23) is capable of entering C3HBi fibroblasts.39 The authors furthermore concluded from these indirect observations that POMs enter cells, but do not aggregate in any cell organelles. Our results newly reveal the presence of large POM aggregates inside cells. While we can only exclude their co-localization with mitochondria on the basis of our study, nothing is currently known with respect to other organelles. However, it may be speculated that POMs (dispersed or in clusters) are encapsulated within membrane-bound vesicles, as reported for silica nanoparticles by Besic Gyenge et al.40
As expected from MTT assays, differential interference contrast (DIC) images (Fig. 5b) demonstrate intact cell morphologies after POM uptake in line with control samples (Fig. S7†). However, one noteworthy difference is evident: cells containing large POM aggregates generally displayed more vacuoles than those without such POM clusters or control cells. However, confocal images also show that these vacuoles do not contain POMs. Their frequent formation may indicate a certain extent of stress on the cells. Whereas our microscopic observations correspond with preceding reports on vacuole appearance in POM-treated cells by Boudinot et al.,41 we could not confirm their hypothesis of POM location within such vacuoles.
We furthermore observed POM-containing HeLa cells during telophase in the late stages of cell cleavage (Fig. 6). Labeled POM aggregates are found over the entire cell cytoplasm and they are equally distributed between the two emerging daughter cells. This points to a certain persistence of POMs within the cellular environment, wherein they are rather accumulated and redistributed than quickly degraded.
![]() | ||
Fig. 6 Confocal picture merged with the DIC image of a HeLa cell during cleavage incubated with 50 μg mL−1 TBA-{P2W17O61Fluo} (green; nucleus: blue) for 24 h. |
Furthermore, POM uptake by HeLa cells was verified by ICP-MS analysis on lyophilized samples (Table 1), and protein contents were determined in parallel (for details cf. Experimental below). Control experiments with or without fluorescein amine in the absence of POMs did not display any tungsten above the analytical detection limits, i.e. background concentrations in cells can be excluded. After treatment with {P2W17O61Fluo}, however, tungsten contents of HeLa cells sharply raised to ca. 3.28 μg mg−1 protein or 0.98 pg per cell, respectively. Interestingly, comparable tungsten amounts were found after treatment of HeLa cells with unlabeled POM (K6[P2W18O62]·16H2O) (2.70 μg mg−1 protein corresponding to 0.81 pg W per cell). These results indicate that fluorescein amine-labeling does not substantially influence the POM uptake process. Most importantly, the cellular uptake of tungsten species provides strong evidence that the observed fluorescence signals (Fig. 5 and 6) indeed arise from intact {P2W17O61Fluo}, given that its stability in neutral media is evident from spectroscopic data (Fig. 2 and S4†).
Total protein [mg] | W [μg mg−1 protein] | W [pg per cellb] | POM [pg per cell] | |
---|---|---|---|---|
a 0 or below detection limit. b Total protein content of HeLa cells was assumed to be 300 pg per cell.42 | ||||
Untreated control | 4.12 | 0.00a | 0.00a | 0.00a |
POM | 3.88 | 2.70 | 0.81 | 1.07 |
POM-Fluo | 3.12 | 3.28 | 0.98 | 1.31 |
Fluorescein amine | 4.02 | 0.00a | 0.00a | 0.00a |
To the best of our knowledge, cellular uptake of POMs has never been determined before with comparable accuracy. Reference data for cellular contents of physiologically less abundant transition metal ions are generally rather rare. Nevertheless, we compared the above results to different metal uptake scenarios, starting with gallium uptake by HL 60 cells as a representative example of a non-essential metal ion.43 Here, considerably lower cellular metal contents of 3.5 × 10−4 pg Ga per cell in comparison with the above tungsten concentrations were observed. Next, we found our tungsten contents to be in the same range as platinum contents in HeLa cells after treatment with cisplatin (1.12 ± 0.07 μg Pt mg−1 protein)44 which indicates that POM levels in HeLa cells might be of interest for further studies. Finally, HeLa cells treated with magnetodendrimers for magnetic resonance tracking contained much more iron (13.6 ± 5.5 pg iron per cell) compared to POM uptake.45
Cellular uptake tests furthermore provided the first evidence of localization of pristine POMs within cells, and two different intracellular distribution patterns were observed. Fluorescent POMs may either appear as randomly dispersed signals over the entire cytoplasm, or aggregated in clusters, which may point towards an organelle-related localization site. Importantly, we found no evidence for POMs entering the nucleus for various concentrations and incubation times, which calls for new in-depth investigations into their empirically observed antiviral and anticancer activity. Tungsten concentrations in HeLa cells are around 0.98 and 0.81 pg W per cell after treatment with labeled and pristine POMs, respectively. Consequently, FITC-labeling does not strongly influence the POM uptake process. The POM contents appear to be in a promising range for further bioactivity studies which are currently underway.
All in all, we introduce new fluorescent labeled POMs as important monitoring agents to directly track their bio-medical modes of action. This approach opens up innovative perspectives to tailor low-cost POM drugs through unprecedented insight into their biochemical interactions and pathways.
FT-IR (KBr): ν = 3458 (m), 3368 (m), 3213 (m), 2962 (s), 2935 (s), 2873 (s), 1747 (m), 1721 (w), 1631 (m), 1616 (m), 1505 (w), 1484 (m), 1463 (m), 1400 (w), 1382 (w), 1327 (w), 1280 (w), 1256 (w), 1242 (w), 1215 (w), 1175 (w), 1096 (s), 955 (s), 895 (s), 792 (s, br), 599 (w), 525 (m).
1H NMR (400 MHz, CD3CN): 0.99 (t, 84H, 2JH–H = 7.3, N(CH2CH2CH2CH3)4), 1.28 (m, 2H, SnCH2), 1.42 (m, 56H, N(CH2CH2CH2CH3)4), 1.65 (m, 56H, N(CH2CH2CH2CH3)4), 2.75 (m, 2H, CH2CO), 3.16 (m, 56H, N(CH2CH2CH2CH3)4), 6.57, 6.69, 6.88, 7.00, 7.07 (m, 9H, Ar-H), 7.22 (m, 1H, NH).
13C NMR (100 MHz, CD3CN): 2.0 (SnCH2), 14.0 (N(CH2CH2CH2CH3)4), 20.4 (N(CH2CH2CH2CH3)4), 24.5 (N(CH2CH2CH2CH3)4), 32.1 (CH2CON), 59.4 (N(CH2CH2CH2CH3)4), 68.3 (Cquat-fluorescein), 103.4, 108.0, 111.0, 112.8, 113.2, 118.3, 123.0, 125.3, 129.3 & 130.3 (CH-arom.), 150.9 & 153.4 (Cquat-arom.), 159.7 (COO), 170.7 (CH2CON).
31P NMR (121.5 MHz, CD3CN): −12.37 (s, 1P, PW9), −10.27 (s, 1P, PW8Sn).
Elemental analysis (%) calcd. for C119H224KN7O67P2W17Sn (6170.10 g mol−1):
C 23.16, H 3.66, N 1.59; found: C 22.52, H 3.60, N 1.12.
UV/vis (CH3CN): 257 nm, 289 nm, 458 nm.
UV/vis (PBS): 238 nm, 259 nm, 280 nm, 457 nm, 489 nm.
TBA6K[α2-P2W17O61{Sn(CH2)2CONHC20H11O5}] (50 mg) was dissolved in CH3CN (1 mL) under sonication and 0.5 mL water was added. The solution was dropped on the column and slowly eluated by a mixture of CH3CN–H2O with increasing water content. The ratios of CH3CN–H2O were: 1:
1, 1
:
2, 1
:
4, 1
:
6, 1
:
8, followed by pure H2O. The solvent was removed under vacuum and the product was obtained as an orange solid.
For ICP-MS analysis the cells in 100 mm dishes were treated as described above for 24 h with 100 μg mL−1 of TBA-{P2W17O61Fluo}, an equalized amount of unlabeled POM (K6[P2W18O62]·16H2O) or an equalized amount of fluorescein amine, respectively. An untreated control was also included. The cells were detached with Trypsin (Sigma), extensively washed 3 times with PBS and subsequently lyophilized. Cellular uptake of tungsten, as the major element in POMs, was quantified in duplicates with ICP-MS techniques at Mikroanalytisches Labor Pascher (Remagen/Germany). In an aliquot of the sample the protein content was measured in parallel with the BCA protein assay kit from Pierce according to manufacturer's instructions. Overall POM uptake was calculated and normalized against the protein content of each sample.
Footnote |
† Electronic supplementary information (ESI) available: 31P NMR spectra of {P2W17O61Fluo} (Fig. S1), 1H and 13C NMR spectra of {P2W17O61Fluo} (Fig. S2 and S3), UV/vis spectra of {P2W17O61Fluo} (Fig. S4), FT-IT spectra of {P2W17O61Fluo} after thermal treatment (Fig. S5), 3D CLSM images of HeLa cells (Fig. S6), CLSM image of control cells (Fig. S7), confocal pictures of HeLa cells after 1 h and 5 h of POM incubation (Fig. S8). See DOI: 10.1039/c3dt50414j |
This journal is © The Royal Society of Chemistry 2013 |